论文部分内容阅读
我们应用免疫组化 (SABC)法对 60例膀胱移行细胞癌患者病理标本中的 Bcl- 2和 TGF- β1基因蛋白进行检测 ,以探讨此方法对判定膀胱移行细胞癌恶性程度和预后的意义。1 资料与方法1 .1组织标本 收集我院手术切除及活检的膀胱癌标本 60例 (病理类型均为移行细胞癌 (TCC) , 级2
We detected the expression of Bcl-2 and TGF-β1 in 60 specimens of bladder transitional cell carcinoma by immunohistochemistry (SABC) method to explore the significance of this method in judging the malignant degree and prognosis of bladder transitional cell carcinoma. 1 Materials and Methods 1.1 tissue samples collected in our hospital surgical resection and biopsy of bladder cancer specimens 60 cases (pathological types are transitional cell carcinoma (TCC), level 2